Biotechnology
Home » Medical Imaging Reagents Market

Medical Imaging Reagents Market

Medical Imaging Reagents Market By Class Type (Contrast Reagents, Optical Reagents, Nuclear Reagents), By Technology (Nanoparticles, Fluorescent Proteins, Fluorescent Dyes And Probes, Radiopharmaceuticals, Quantum Dots), By Application (Diagnostics, Drug Discovery And Development, Research And Development) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022
Report Book

Published Date: June 2016
Category: Biotechnology
Report ID: 57910
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

This report on the global medical imaging reagents market studies various technologies, classes, and applications of medical imaging reagents in healthcare. Rapid medical research development produces a continuous stream of new knowledge about disease processes, new therapeutic targets, and the complex relationship between a person’s genome and his/her related risk for disease. Therefore, medical imaging is expected to play a crucial role in the global healthcare system as it contributes to improved patient outcomes and cost-efficient healthcare in all major disease entities.

For this study, the global medical reagent market has been segmented on the basis of class type, technology, application, and geography. The class studies the medical reagents market, including contrast reagents, optical reagents, and nuclear reagents. Market size estimates and forecasts for these segments for the period 2013 to 2022 are provided in terms of revenue (USD Mn) along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The global medical reagent market has been segmented on the basis of application and technology. The application segments include diagnostics, drug discovery and development, and research and development. On the basis of technology, the medical reagent market is segmented as nanoparticles, fluorescent proteins, fluorescent dyes and probes, radiopharmaceuticals, and quantum dots. Market size estimates and forecasts for these segments for 2013 to 2022 are provided in terms of revenue (USD Mn) along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The medical imaging reagents market has been geographically categorized into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments from 2013 to 2022 are provided in terms of revenue (USD Mn) and volume (no. of units), along with the respective CAGRs for the period 2016 to 2022 this report.

The major key players profiled in the medical imaging reagents market are on the basis of various characteristics such as business description, financial health, budget allocation, product portfolio, and news coverage. The major players profiled in this report include Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, Cardinal Health, Inc., GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals and Thermo Fisher Scientific, Inc.

Based on the type of application, the global medical imaging reagents market is segmented as follows:

  • Diagnostics
  • Drug Discovery and Development
  • Research and Development

In 2015, diagnostic was observed as the major application in the medical imaging reagents market, followed by drug discovery and development. The key factors assisting the growth of the diagnostic applications segment are increasing support of governmental and non-governmental bodies to increase public enrollment associated with early disease diagnosis, rising prevalence of lifestyle diseases due to sedentary lifestyle, and increasing awareness campaigns associated with the life-threatening disease diagnosis across the globe. However, drug discovery and development was observed as the fastest-growing application segment due to the growing adoption rate of medical imaging reagents in pre-clinical studies and medical interventions. According to market experts, drug discovery and development scientists utilizes a wide array of imaging technologies, including MRI, microCT, micro-PET, SPECT, X-Ray, and optical (two-dimensional and fluorescence molecular tomography) to quantitatively assess test agent performance at anatomical, functional, and molecular levels. In addition, molecular imaging technologies can also be utilized to conduct application research to develop and optimize the use of imaging to further advance imaging in the field of drug discovery.

Technology Segmentation Analysis

The technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes, and probes. In the base year 2015, nanoparticles technology was observed as the fastest growing segment at a CAGR of around 9% during the forecast period 2016 to 2022 due to the broad range of applications along with rising research and development initiatives being taken to develop an enhanced form of medical imaging reagents. Based on the technology used, the medical imaging reagent market is segmented into the following:

  • Nanoparticles
  • Fluorescent proteins
  • Radiopharmaceuticals
  • Quantum dots

The market for imaging reagents is currently led by radiopharmaceuticals for nuclear medicine imaging. The market for these reagents is expected to grow with an average annual rate of around 9% during the forecast period. According to market experts, in the near future, advanced medical equipment will be minimally invasive in nature and easy to apply, which might ultimately induce novel technologies and products in the medical imaging reagents market. The mapping of the radiopharmaceutical distribution in vivo provides images of the functional morphology of organs in a non-invasive manner and plays an important role in the diagnosis of many common diseases associated with the malfunctioning of organs in the body as well as in the detection of a certain type of cancers. The widespread utilization and growing demands for these techniques are directly attributable to the development and availability of a vast range of specific radiopharmaceuticals. Thus, significant growth will be observed in the medical imaging reagents market throughout 2016 – 2022.

For this study, the global medical imaging reagent market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In 2015, North America was the largest market for medical imaging reagents due to the rising incidences of cancer, cardiovascular and neurological diseases, and high awareness strategies applied by governmental and non-governmental bodies to prefer enhanced imaging modalities and reagents. The other factors assisting the growth of medical imaging reagents are high healthcare expenditure and high public awareness associated with lifestyle disease diagnosis for maintenance. During 2016- 2022, Asia-Pacific is expected to experience the highest growth rate due to strong economic developments, the high incidence rate of cardiovascular diseases, and increasing demand for non-ionizing imaging reagents. The market experts suggest that, because of the region’s population size and rapid economic transformation, many scholars have researched the Asia-Pacific region’s ongoing demographic shift and its future, which suggests the diagnostic imaging market of this region will grow at a significant rate.

Based on the type of application, the global medical imaging reagents market is segmented as follows:

  • Diagnostics
  • Drug Discovery and Development
  • Research and Development

In 2015, diagnostic was observed as the major application in the medical imaging reagents market, followed by drug discovery and development. The key factors assisting the growth of the diagnostic applications segment are increasing support of governmental and non-governmental bodies to increase public enrollment associated with early disease diagnosis, rising prevalence of lifestyle diseases due to sedentary lifestyle, and increasing awareness campaigns associated with the life-threatening disease diagnosis across the globe. However, drug discovery and development was observed as the fastest-growing application segment due to the growing adoption rate of medical imaging reagents in pre-clinical studies and medical interventions. According to market experts, drug discovery and development scientists utilizes a wide array of imaging technologies, including MRI, microCT, micro-PET, SPECT, X-Ray, and optical (two-dimensional and fluorescence molecular tomography) to quantitatively assess test agent performance at anatomical, functional, and molecular levels. In addition, molecular imaging technologies can also be utilized to conduct applied research to develop and optimize imaging further to advance imaging in the field of drug discovery.

Technology Segmentation Analysis

The technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes, and probes. In the base year 2015, nanoparticles technology was observed as the fastest growing segment at a CAGR of around 9% during the forecast period 2016 to 2022 due to the broad range of applications along with rising research and development initiatives being taken to develop an enhanced form of medical imaging reagents. Based on the technology used, the medical imaging reagent market is segmented into the following:

  • Nanoparticles
  • Fluorescent proteins
  • Radiopharmaceuticals
  • Quantum dots

The market for imaging reagents is currently led by radiopharmaceuticals for nuclear medicine imaging. The market for these reagents is expected to grow with an average annual rate of around 9% during the forecast period. According to market experts, in the near future, advanced medical equipment will be minimally invasive and easy to apply, which might induce novel technologies and products in the medical imaging reagents market. The mapping of the radiopharmaceutical distribution in vivo provides images of the functional morphology of organs in a non-invasive manner and plays an important role in the diagnosis of many common diseases associated with the malfunctioning of organs in the body in the detection of a certain types of cancers. The widespread utilization and growing demands for these techniques are directly attributable to the development and availability of a vast range of specific radiopharmaceuticals. Thus, significant growth will be observed in the medical imaging reagents market throughout 2016 – 2022.

For this study, the global medical imaging reagent market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In the base year 2015, North America was observed as the largest market for medical imaging reagents due to the rising incidences of cancer, cardiovascular and neurological diseases, and high awareness strategies applied by governmental and non-governmental bodies specifically to prefer enhanced imaging modalities and reagents. The other factors assisting the growth of medical imaging reagents are high healthcare expenditure and high public awareness associated with lifestyle disease diagnosis for maintenance. During 2016- 2022, Asia-Pacific is expected to experience the highest growth rate due to strong economic developments, the high incidence rate of cardiovascular diseases, and increasing demand for non-ionizing imaging reagents. The market experts suggest that, because of the region’s population size and rapid economic transformation, many scholars have researched the Asia-Pacific region’s ongoing demographic shift and its future, which suggests the diagnostic imaging market of this region will grow at a significant rate.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Medical Imaging Reagents Market, by Class Type, 2015 (USD Mn)
2.2 Medical Imaging Reagents Market Share, by Technology, 2015 & 2022 (Value %)
2.3 Medical Imaging Reagents Market Share, by Application, 2013 to 2022 (USD Mn)
2.4 Medical Imaging Reagents Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Medical Imaging Reagents Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.1.1 Medical Imaging Reagents Technologies: Current and Future Trends
3.1.1.1 Medical Imaging Reagents Market: New Developments In Contrast Agents
3.1.1.2 Medical Imaging Reagents Market: New Developments In Computed Tomography
3.1.1.3 Medical Imaging Reagents Market: New Developments In Magnetic Resonance Imaging
3.1.1.4 Medical Imaging Reagents Market: New Developments In Positron Emission Tomography
3.1.1.5 Medical Imaging Reagents Market: New Developments In Ultrasound
3.1.1.6 Medical Imaging Reagents Market: New Developments In Radiography
3.1.2 Medical Imaging Reagents Market: Reimbursement Scenario
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Medical Imaging Reagents Manufacturers, 2015 (%)

Chapter 4 Global Medical Imaging Reagents Market Analysis, by Class Type (USD Mn)
4.1 Preface
4.2 Contrast Reagents
4.3 Optical Reagents
4.4 Nuclear Reagents

Chapter 5 Global Medical Imaging Reagents Market Analysis, by Technology (USD Mn)
5.1 Preface
5.2 Nanoparticles
5.3 Fluorescent Proteins
5.4 Fluorescent Dyes and Probes
5.5 Radiopharmaceuticals
5.6 Quantum Dots

Chapter 6 Global Medical Imaging Reagents Market Analysis, by Application (USD Mn)
6.1 Preface
6.2 Diagnostics
6.3 Drug Discovery and Development
6.4 Research and Development

Chapter 7 Global Medical Imaging Reagents Market, by Geography (USD Mn)
7.1 Preface
7.2 North America
7.2.1 U.S
7.2.2 Canada
7.3 Europe
7.3.1 U.K
7.3.2 Germany
7.3.3 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 Rest of Asia Pacific
7.5 Latin America (LATAM)
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of LATAM
7.6 Middle East and Africa (MEA)

Chapter 8 Future Growth Advocacies

Chapter 9 Company Profiles
9.1 Bayer Healthcare AG
9.1.1 Business Description
9.1.2 Financial Health and budget allocation
9.1.3 Product Positions/Portfolio
9.1.4 Key Competitors
9.1.5 News Coverage
9.2 Danaher Corporation
9.2.1 Business Description
9.2.2 Financial Health and Budget Allocation
9.2.3 Product Positions/Portfolio
9.2.4 Key Competitors
9.2.5 News Coverage
9.3 Becton Dickinson & Company
9.3.1 Business Description
9.3.2 Financial Health and Budget Allocation
9.3.3 Product Positions/Portfolio
9.3.4 Key Competitors
9.3.5 News Coverage
9.4 Bracco Imaging SpA
9.4.1 Business Description
9.4.2 Financial Health and budget allocation
9.4.3 Product Positions/Portfolio
9.4.4 Key Competitors
9.4.5 News Coverage
9.5 Cardinal Health, Inc.
9.5.1 Business Description
9.5.2 Financial Health and budget allocation
9.5.3 Product Positions/Portfolio
9.5.4 Key Competitors
9.5.5 News Coverage
9.6 Lantheus Medical Imaging, Inc.
9.6.1 Business Description
9.6.2 Financial Health and budget allocation
9.6.3 Product Positions/Portfolio
9.6.4 Key Competitors
9.6.5 News Coverage
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Business Description
9.7.2 Financial Health and budget allocation
9.7.3 Product Positions/Portfolio
9.7.4 Key Competitors
9.7.5 News Coverage
9.8 Promega Corporation
9.8.1 Business Description
9.8.2 Financial Health and budget allocation
9.8.3 Product Positions/Portfolio
9.8.4 Key Competitors
9.8.5 News Coverage
9.9 Siemens Healthcare
9.9.1 Business Description
9.9.2 Financial Health and budget allocation
9.9.3 Product Positions/Portfolio
9.9.4 Key Competitors
9.9.5 News Coverage
9.10 Thermo Fisher Scientific, Inc.
9.10.1 Business Description
9.10.2 Financial Health and budget allocation
9.10.3 Product Positions/Portfolio
9.10.4 Key Competitors
9.10.5 News Coverage

List of Figures

FIG. 1 Medical Imaging Reagents : Market Segmentation
FIG. 2 Medical Imaging Reagents Market, by Class Type, 2015 (USD Mn)
FIG. 3 Medical Imaging Reagents Market Share, by Technology, 2015 & 2022 (Value)
FIG. 3 Medical Imaging Reagents Market Share, by Application, 2013 to 2022 (USD Mn)
FIG. 4 Medical Imaging Reagents Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Medical Imaging Reagents Market, 2015
FIG. 6 Key Players Market Share Analysis for X-ray Devices, 2015(%)
FIG. 7 Global Contrast Reagents Market, 2013 – 2022 (USD Mn)
FIG. 8 Global Optical Reagents Market, 2013 – 2022 (USD Mn)
FIG. 9 Global Nuclear Reagents Market, 2013 – 2022 (USD Mn)
FIG. 10 Global Nanoparticles Market, 2013 – 2022 (USD Mn)
FIG. 11 Global Fluorescent Proteins Market, 2013 – 2022 (USD Mn)
FIG. 12 Global Fluorescent Dyes and Probes Market, 2013 – 2022 (USD Mn)
FIG. 13 Global Radiopharmaceuticals Market, 2013 – 2022 (USD Mn)
FIG. 14 Global Quantum Dots Market, 2013 – 2022 (USD Mn)
FIG. 15 Global Diagnostics Market, 2013 – 2022 (USD Mn)
FIG. 16 Global Drug Discovery and Development Market, 2013 – 2022 (USD Mn)
FIG. 17 Global Research and Development Market, 2013 – 2022 (USD Mn)
FIG. 18 Global U.S. Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 19 Global Canada Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 20 Global U.K. Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 21 Global Germany Medical Imaging Reagents Market, 2013 – 2022 (USDMn)
FIG. 22 Global Rest of Europe Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 23 Global Japan Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 24 Global China Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 25 Global Rest of Asia-Pacific Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 26 Global Brazil Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 27Global Mexico Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)
FIG. 28Global Rest of LATAM Medical Imaging Reagents Market, 2013 – 2022 (USD Mn)

Frequently Asked Questions

What is the size of Medical Imaging Reagents Market?

The market for Medical Imaging Reagents Market is expected to reach US$ XX Bn in 2027.

What is the Medical Imaging Reagents Market CAGR?

The Medical Imaging Reagents Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Medical Imaging Reagents Market?

The report is forecasted from 2018-2027.

What is the base year considered for Medical Imaging Reagents Market?

The base year of this report is 2021.

Who are the major players in this market?

Bayer Healthcare AG, Danaher Corporation, Becton Dickinson & Company, Bracco Imaging SpA, Harris are some of the major players in the global market.

Biotechnology

Mass Spectrometry Market

Published Date: Aug. 2023
Category: Biotechnology
Report ID: 58466
Report Format: PDF
No of Pages: 246

Biotechnology

Aptamers Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 59152
Report Format: PDF
No of Pages: 240

Biotechnology

Biologic Imaging Reagents Market

Published Date: August 2023
Category: Biotechnology
Report ID: 62085
Report Format: PDF
No of Pages: 215

Biotechnology

Agriculture Biotechnology Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62073
Report Format: PDF
No of Pages: 228

Biotechnology

Monoclonal Antibody Custom Service Market

Published Date: August 2023
Category: Biotechnology
Report ID: 62059
Report Format: PDF
No of Pages: 243

Biotechnology

Capsule Endoscope and Workstation Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62054
Report Format: PDF
No of Pages: 225

Biotechnology

Cell Separation Technologies Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62053
Report Format: PDF
No of Pages: 247

Biotechnology

DNA Probe-Based Diagnostics Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62051
Report Format: PDF
No of Pages: 228

Biotechnology

Terpenes Market

Published Date: August 2023
Category: Biotechnology
Report ID: 60946
Report Format: PDF
No of Pages: 166

Biotechnology

Cell Isolation And Separation Market

Published Date: July 2023
Category: Biotechnology
Report ID: 59149
Report Format: PDF
No of Pages: 224

Biotechnology

Biological Product Manufacturing Market

Published Date: July 2023
Category: Biotechnology
Report ID: 61994
Report Format: PDF
No of Pages: 232

Biotechnology

Mobile Water Treatment Systems Market

Published Date: July 2023
Category: Biotechnology
Report ID: 61323
Report Format: PDF
No of Pages: 232

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now